This is a working overview of mass spectrometry, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-03. Anything still debated is marked as such rather than presented as settled.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 0.9 kDa | Depends on exact fragment sequence and counterion |
| Amino acid sequence | LKKTETQ (commonly cited) | Short actin-binding motif from thymosin beta-4 |
| Common salt form | Acetate salt | Trifluoroacetate also reported in research material |
| Reconstitution solvent | Sterile water or buffer | Gentle mixing; avoid vigorous agitation |
| Solution storage | -20 °C or lower | Aliquot to avoid repeated freeze-thaw cycles |
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
At the 1990 FIFA World Cup, Colombia were drawn in Group D with Yugoslavia, the United Arab Emirates and West Germany. They opened at the Stadio Renato Dall'Ara in Bologna on 9 June with a laboured 2–0 win over the United Arab Emirates, Bernardo Redín heading in Leonel Álvarez's pass in the 50th minute and Carlos Valderrama driving home from twenty yards five minutes from time — Colombia's first victory at a World Cup finals. A 1–0 defeat by Yugoslavia left qualification resting on the final group match against West Germany in Milan on 19 June. Pierre Littbarski put the eventual world champions ahead in the 88th minute; with the last attack of the match, Freddy Rincón collected a through-ball from Valderrama and beat Bodo Illgner to secure the 1–1 draw and the point Colombia needed. Colombia finished third in Group D and advanced to the round of 16, their first appearance in a World Cup knockout round. The round-of-16 tie against Cameroon at the Stadio San Paolo on 23 June remained goalless through 90 minutes. In extra time, the 38-year-old Roger Milla scored twice in three minutes, the second after intercepting René Higuita far outside his penalty area as the goalkeeper attempted to dribble past him; Redín replied with five minutes remaining, and Cameroon won 2–1 to become the first African side to reach a World Cup quarter-final. Maturana departed shortly after the tournament and was succeeded by Luis Augusto García.
== Uses == Industry, agriculture, and other sectors employ many poisonous substances, usually for reasons other than their toxicity to humans. Examples include medicines (e.g. anthelmintics used on chickens), solvents (e.g. rubbing alcohol, turpentine), cleaners (e.g. bleach, ammonia), coatings (e.g. arsenic wallpaper), and feedstocks. The toxicity itself sometimes has economic value, when it serves agricultural purposes such as weed control and pest control. Most poisonous industrial compounds have associated material safety data sheets and are classified as hazardous substances. Hazardous substances are subject to extensive regulation on production, procurement, and use in overlapping domains of occupational safety and health, public health, drinking water quality standards, air pollution, and environmental protection. Due to the mechanics of molecular diffusion, many poisonous compounds rapidly diffuse into biological tissues, air, water, or soil on a molecular scale. By the principle of entropy, chemical contamination is typically costly or infeasible to reverse, unless specific chelating agents or micro-filtration processes are available. Chelating agents are often broader in scope than the acute target, and therefore their ingestion necessitates careful medical or veterinarian supervision. Pesticides are one group of substances whose prime purpose is their toxicity to various insects and other animals deemed to be pests (e.g., rats and cockroaches). Natural pesticides have been used for this purpose for thousands of years (e.g.
Gorky Park (officially the Central Park of Culture and Rest), named after writer Maxim Gorky, was founded in 1928. The main area (689,000 square meters or 170 acres) along the Moskva River contains estrades (raised platforms), children's attractions—including the Observation Wheel, as well as ponds with boats and water bicycles—dancing, tennis courts, and other sports facilities. Gorky Park borders the Neskuchny Garden (408,000 square meters or 101 acres), the oldest park in Moscow and a former imperial residence, created as a result of integrating three estates during the 18th century. The garden features the Green Theater, one of the largest open amphitheaters in Europe, able to contain up to 15 thousand people. Several parks include a section known as a "Park of Culture and Rest", sometimes alongside a wilder area. (Such parks include Izmaylovsky, Fili, and Sokolniki.) Some parks are designated Forest Parks (lesopark).
Despite its apparent importance in hydrogen peroxide removal, humans with genetic deficiency of catalase — "acatalasemia" — or mice genetically engineered to lack catalase completely, experience few ill effects.
==== MeSH E05.196.712 – photometry ==== MeSH E05.196.712.224 – densitometry MeSH E05.196.712.224.187 – absorptiometry, photon MeSH E05.196.712.224.375 – densitometry, x-ray MeSH E05.196.712.516 – luminescent measurements MeSH E05.196.712.516.200 – chemiluminescent measurements MeSH E05.196.712.516.600 – fluorometry MeSH E05.196.712.516.600.240 – cytophotometry MeSH E05.196.712.516.600.240.350 – flow cytometry MeSH E05.196.712.516.600.240.400 – image cytometry MeSH E05.196.712.516.600.240.400.500 – laser scanning cytometry MeSH E05.196.712.516.600.390 – fluorescence polarization MeSH E05.196.712.516.600.390.350 – fluorescence polarization immunoassay MeSH E05.196.712.516.600.393 – fluorescence recovery after photobleaching MeSH E05.196.712.516.600.410 – fluorophotometry MeSH E05.196.712.516.600.676 – spectrometry, fluorescence MeSH E05.196.712.516.600.676.500 – fluorescence resonance energy transfer MeSH E05.196.712.650 – nephelometry and turbidimetry MeSH E05.196.712.726 – spectrophotometry MeSH E05.196.712.726.300 – microspectrophotometry MeSH E05.196.712.726.551 – spectrophotometry, atomic MeSH E05.196.712.726.676 – spectrophotometry, infrared MeSH E05.196.712.726.676.700 – spectroscopy, fourier transform infrared MeSH E05.196.712.726.802 – spectrophotometry, ultraviolet
Sources: en.wikipedia.org
== Detection technique == Helium is used as a tracer because it penetrates small leaks rapidly. Helium also has the properties of being non-toxic, chemically inert and present in the atmosphere only in minute quantities (<6 ppm). Typically a helium leak detector will be used to measure leaks in the range of 10−5 to 10−12 Pa·m3·s−1. When a mass spectrometer is used to sample the leaking helium leaks can be detected up to 10−14 Pa·m3·s−1. A flow of 10−5 Pa·m3·s−1 is about 0.006 ml per minute at standard conditions for temperature and pressure (STP). A flow of 10−13 Pa·m3·s−1 is about 0.003 ml per century at STP.
== Pharmacology == CVnCoV is an mRNA vaccine that encodes the full-length, pre-fusion stabilized coronavirus spike protein, and activates the immune system against it. CVnCoV technology does not interact with the human genome. CVnCoV uses unmodified RNA, unlike the Pfizer–BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine, which both use nucleoside-modified RNA.
From the Genroku period, "chazukeya" appeared as restaurants serving chazuke, and they were widely popular as fast food for common people. The Edo Meisho Zue, a travel guide written in the late Edo period, mentions chazuke restaurants plainly, suggesting they were common at the time.
=== Pharmacokinetics === N-Desalkylflurazepam has an elimination half-life of 47–150 hours (up to 200 hours in some healthy volunteers), with an average of ~71 hours. Peak blood concentrations of N-Desalkylflurazepam is reached at 10.2 h following a single 15 mg dose of Flurazepam, typically around ~10-20.4 ng/mL. Its plasma levels are unreliable amongst patients, and are largely influenced by liver disease, liver enzyme inducers and inhibitors, as well as old age (in men).
Sources: en.wikipedia.org
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.
Reversed-phase liquid chromatography separates components and reports purity from peak area. Mass spectrometry confirms the molecular mass expected for the sequence. Additional approaches such as peptide mapping or amino acid analysis provide independent confirmation.
Reported percentages depend on the analytical method, the detection wavelength, and whether salts and water are counted. A value above ninety-five percent by chromatography does not by itself establish a correct sequence. Different suppliers also calculate purity against different reference standards.
Divide it into single-use aliquots and hold them frozen at -20 °C or below, protected from light. Repeated thawing of one container is the main avoidable source of variability.